Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Extension of Accordion Pill Carbidopa/Levodopa in Parkinson's Disease
NCT02615873Phase 3Unknown
- Sponsor
- Intec Pharma Ltd.
- Start
- Jul 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of carbidopa, levodopa in Parkinson's disease (PD), sponsored by Intec Pharma Ltd.. Status: unknown.
02
Drugs
carbidopalevodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02615873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02615873.